Home›Stock Screener›Vineet Laboratories

Vineet Laboratories Share Price Today | Stock Price & Vineet Laboratories Share Screener

VINEETLAB Pharmaceuticals & Biotechnology
Live Share Price NSE
₹38.39
▲ 1.34 (3.62%)
2026-11-18 00:00:00
Live Share Price BSE
₹37.80
▲ 0.77 (2.08%)
2026-11-18 00:00:00

As of November 18, 2026, the live Vineet Laboratories share price (NSE: VINEETLAB) is ₹38.39 on NSE and ₹37.80 on BSE, up 3.62% from the previous close, with shares trading between ₹36.16 and ₹39.00 in today's trading session, and a 52-week range of ₹29.01–₹44.62. Track VINEETLAB market capitalization to gauge the company's total market size. Use the Vineet Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Vineet Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹59 and net income of ₹3, with EBITDA of ₹10, an operating margin of 17.0% and a profit margin of 5.1%.

Vineet Laboratories Market Cap ₹71.16 Cr.
VINEETLAB P/E Ratio (TTM) 22.60
Vineet Laboratories P/B Ratio 1.53
EPS (TTM) ₹1.00
Dividend Yield 2.67%
Debt to Equity 1.71
VINEETLAB 52 Week High ₹44.62
Vineet Laboratories 52 Week Low ₹29.01
Operating Margin 17.00%
Profit Margin 5.08%
VINEETLAB Revenue (TTM) ₹59.00
EBITDA ₹10.00
Net Income ₹3.00
Total Assets ₹125.00
Total Equity ₹46.00

Vineet Laboratories Share Price Chart

Track the current stock price of Vineet Laboratories with an interactive chart. Analyse VINEETLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vineet Laboratories stock quote in one place.

The quote of ₹38.39 sits between the 52-week low of ₹29.01 and the 52-week high of ₹44.62, and the latest session moved 3.62% from the previous close.

Vineet Laboratories Company Profile - Fundamental Screener

Screen Vineet Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VINEETLAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE505Y01010.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE505Y01010

Vineet Laboratories Balance Sheet Screener

Screen VINEETLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹125, up from ₹95 in 2025.

Latest statistics put total assets at ₹125 and shareholder funds at ₹46, with a leverage ratio of 1.71.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 125 95 117 116 133 109 0 0
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 24 26 27 27 21 20 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 12 6 6 8 5 8 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 46 15 35 34 33 27 0 0
Share Capital 19 9 9 9 9 9 0 0
Reserves & Surplus 26 5 26 25 24 17 0 0

Vineet Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Vineet Laboratories income statement and profit fundamentals. Analyze VINEETLAB quarterly results. Vineet Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹59 and net profit was ₹3, equal to earnings per unit of ₹2.20, at an operating margin of 17%.

In that period expenses were ₹50, interest cost ₹3 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹59 and net profit of ₹1.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Revenue and Expenses

Revenue 59 59 77 151 212 192 244 0 0
Expenses 50 51 91 143 205 178 235 0 0

Operating Costs and Margins

EBITDA 10 8 -14 8 8 13 9 0 0
Operating Profit % 17.00% 14.00% -22.00% 5.00% 4.00% 7.00% 3.00% 0.00% 0.00%
Depreciation 2 2 3 3 2 2 2 0 0
Interest 3 5 4 5 3 2 3 0 0

Profit and Earnings

Profit Before Tax 4 1 -21 0 2 9 4 0 0
Tax 1 0 -1 -1 1 3 2 0 0
Net Profit 3 1 -20 1 1 7 2 0 0
EPS 2.20 1.00 -21.90 1.11 1.36 7.16 2.18 -0.27 0.00

Vineet Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen VINEETLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹12.

Over the same period, investing activities used ₹3 and financing activities used ₹8.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 12 -7 -10 8 28 0
Investing Activities -3 -2 -7 -4 -8 0

Financing and Net Cash

Financing Activities -8 8 0 12 19 0
Net Cash Flow 0 0 -16 16 38 0

Vineet Laboratories Shareholding Pattern Screener

See Vineet Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Vineet Laboratories promoter holding and ownership changes for VINEETLAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Sept, promoters held 5.98%, foreign institutions 0.24%, domestic institutions 0.00% and the public 80.61%, spread across 9,724 shareholders.

The shareholder count was 9,724 in 2026-Sept, compared with 9,901 in 2026-Jun.

Item 2026-Sept 2026-Jun 2026-Mar 2026-Feb 2025-Dec 2025-Sept 2025-Jun 2025-Mar

Promoter Holding

Promoter Holding 5.98% 5.98% 5.98% 5.98% 12.46% 15.89% 29.26% 35.85%

Institutional Investors

FII Holding 0.24% 0.50% 0.36% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 80.61% 88.17% 88.74% 89.17% 82.41% 78.16% 66.95% 58.67%
Other Holding 13.17% 5.34% 4.92% 4.84% 5.12% 5.94% 3.79% 5.49%
Shareholder Count 9,724 9,901 9,929 10,042 10,003 9,682 9,988 10,025

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vineet Laboratories. Vineet Laboratories dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹1.00 2.86%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Vineet Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Vineet Laboratories stock. Check VINEETLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Vineet Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Vineet Laboratories Market Events Screener - Corporate Actions

Get Vineet Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vineet Laboratories stock events that may affect VINEETLAB share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated November 30, 2026, with a record date of November 30, 2026.

It is followed by Quarterly Result Announcement dated November 12, 2026 and Quarterly Result Announcement dated October 26, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-30 2026-11-30 Annual General Meeting NA 3.11%
2026-11-12 2026-11-12 Quarterly Result Announcement NA 2.23%
2026-10-26 2026-10-26 Quarterly Result Announcement NA -6.38%
2026-08-25 2026-08-25 Quarterly Result Announcement NA 8.61%
2026-07-15 2026-07-15 Quarterly Result Announcement NA 7.51%
2026-02-14 2026-02-14 Quarterly Result Announcement NA -1.49%
2026-02-07 2026-02-07 Extraordinary General Meeting NA -14.72%
2025-12-23 2025-12-23 Rights 13:12 0.84%
2025-11-08 2025-11-08 Quarterly Result Announcement NA -2.38%
2025-10-23 2025-10-23 Quarterly Result Announcement NA 2.39%
2025-09-25 2025-09-25 Annual General Meeting NA 26.25%
2025-07-22 2025-07-22 Quarterly Result Announcement NA -19.58%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -13.11%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -6.92%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 2.63%

Vineet Laboratories Competitors Screener - Peer Stocks Comparison

Screen VINEETLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,676 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 295,997 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,586 85.00 13,886 20.34% 2,138 47.23
Laurus Labs 126,325 89.90 6,868 22.01% 890 57.04
Zydus Life Science 120,119 27.60 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 115,854 41.80 35,059 3.90% 4,158 71.26
Cipla 112,131 39.50 29,045 2.24% 3,870 53.06
Mankind Pharma 107,805 47.90 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,229 25.80 34,145 5.56% 3,503 60.39
Lupin 89,172 17.30 29,039 26.75% 5,356 39.39

Vineet Laboratories Company Announcements - News & Reports Screener

Screen VINEETLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated November 16, 2026 and November 15, 2026.

Date Update Actions
2026-11-19 Intimation-Newspaper Publication Of Financial Results For The Quarter Ended 30.09.2026 -
2026-11-16 Statement Of Deviation & Variation For September 30 2026 -
2026-11-15 Board Meeting Outcome for Results For The Quarter And Half Year Ended 30.09.2026 -
2026-11-15 Results For The Quarter And Half Year Ended 30.09.2026 -
2026-11-15 Intimation-Newspaper Publication Of Notice Of 10Th Annual General Meeting Of The Company For The Financial Year 2025-26. -
2026-11-10 Intimation Of Book Closure Regarding 10Th Annual General Meeting -
2026-11-10 Notice Of The AGM To Be Held On 30.11.2026 -
2026-11-10 Reg. 34 (1) Annual Report. -
2026-11-06 Board Meeting Intimation for Approval Of Unaudited Finanicial Results For The Quarter Ended 30.09.2026 -
2026-11-04 Appointment Of Internal Auditor Of The Company -
2026-11-04 Resignation Of Internal Auditor Of The Company -
2026-11-04 Appointment Of Cost Auditor Of The Company -
2026-11-04 Appointment Of Secretarial Auditor Of The Company -
2026-11-04 Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s -
2026-11-04 Resignation Of Secretarial Auditor Of The Company -
2026-11-04 Resignation Of Cost Auditor Of The Company -
2026-11-04 Board Meeting Outcome for Outcome Of The Board Meeting Held On 04.11.2026 -
2026-10-30 Board Meeting Intimation for Meeting To Be Held On 04.11.2026 -
2026-10-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-26 Reg. 32(1) (3) - Statement Of Deviation & Variation For June 30 2026 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹38.39, within a 52-week range of ₹29.01 to ₹44.62. The P/E ratio is 22.60 and the P/B ratio is 1.53, with earnings per unit of ₹1.00. Market capitalisation stands at ₹71.16 Cr and the dividend yield is 2.67%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 20, 2026. This page covers 8 balance sheet periods, 9 income statement periods, 6 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.